Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases

British Journal of Cancer

Volumn 83, Issue 12, 2000, Pages 1707-1714

  Palmieri, G ^a   Cossu, A ^b   Ascierto, P A ^c   Botti, G ^c   Strazzullo, M ^c   Lissia, A ^b   Colombino, M ^a   Casula, M ^a   Floris, C ^d   Tanda, F ^b   Pirastu, M ^a   Castello, G ^c  

^a CNR   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d Ospedale Oncologico A Businco   (Italy)

Author keywords

Chromosome 9p21, polymerase chain reaction; Malignant melanoma; Microsatellite analysis; Tumour progression

Indexed keywords

PROTEIN P15; PROTEIN P16; PROTEIN P19;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER STAGING; CHROMOSOME 9P; FEMALE; GENE DELETION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY LOSS; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MELANOMA; METASTASIS; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN METASTASIS; VISCERA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHROMOSOMES, HUMAN, PAIR 9; DNA, NEOPLASM; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MELANOMA; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM METASTASIS;

EID: 17744386133     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1513     Document Type: Article

References (45)

1. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors
2. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia
3. Melanoma epidemiology
4. Detection of microsatellite alterations in the spectrum of melanocytic nevi in patients with or without individual or family history of melanoma
5. Novel p16 mutation in familial melanoma in Southern Sweden
6. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
7. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation
8. Prelevance of germ-line mutations in p16, p19(ARF), and CDK4 in familial melanoma: Analysis of a clinic-based population
9. Loss of the p16(INK4a) and p15(INK4b) genes, as well as neighboring 9p21 markers, in sporadic melanoma
10. The CDKN2A (p16) gene and human cancer
11. Homozygous deletion within human chromosome band 9p21 in melanoma
12. p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma
13. Low frequency of p16/CDKN2A methylation in sporadic melanoma: Comparative approaches for methylation analysis of primary tumors
14. Molecular genetics of familial cutaneous melanoma
15. Loss of heterozygosity in sporadic primary cutaneous melanoma
16. Infrequent mutation of p16INK4 in sporadic melanoma
17. Prognostic significance of allelic losses in primary melanoma
18. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
19. A cell cycle regulator potentially involved in genesis of many tumor types
20. Loss of heterozygosity at chromosome 9p21 (INK4-pl4ARF locus): Homozygous deletions and mutations in the p16 and p14ARF genes in sporadic primary melanomas
21. Genetic alterations of p16INK4a and p53 genes in sporadic dysplastic nevus
22. Methylation and p16: Suppressing the suppressor
23. Affected members of melanoma-prone families with linkage to 9p21 but laking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19(ARF)
24. Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma
25. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma
26. 5' CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers
27. Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression
28. Deletions of the cyclin dependent Kinase-4 inhibitor gene in multiple human cancers
29. Two target regions of allelic loss on chromosome 9 in urinary-bladder cancer
30. Deletion mapping of chromosome 9p21-p22 surronding the CDKN2 locus in melanoma
31. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression
32. High frequency of deletion on chromosome 9p21 may harbor several tumor-suppressor genes in human prostate cancer
33. Microsatellite instability and loss of heterozygosity in melanoma
34. Identification of a founder BRCA2 mutation in Sardinia
35. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families withh ereditary cutaneous melanoma
36. Compilation of somatic mutations of the CDKN2 gen in human cancers: Non-random distribution of base substitutions
37. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocityc lesion correlates with invasive stage of tumor progression
38. Analysis of tumor cell evolution in a melanoma: Evidence of mutational and selective pressure for loss of p16ink4 and for microsatellite instability
39. Retention of the CDKN2A locus and low frequency of point mutations in primary and metastatic cutaneous malignant melanoma
40. Melanoma and other skin neoplasms
41. CDKN2A [P16(INK4A)] somatic and germline mutations
42. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France
43. Microsatellite instability in malignant melanoma
44. Homozygous deletion of the p16INK4a and the p15INK4b tumour suppressor genes in a subset of human sporadic cutaneous malignant melanoma
45. Germline mutations in the p16(INK4a) binding domain of CDK4 in familial melanoma